|
EP2970916B1 |
14 Apr, 2021
|
Adapted Lepidopteran Insect Cells For The Production Of Recombinant Proteins
|
NA
|
2
| |
|
EP2935329B1 |
16 Sep, 2020
|
Antibodies That Bind To Human Programmed Death Ligand 1 (Pd-L1)
|
NA
|
2
| |
|
EP3165220B1 |
03 Apr, 2019
|
Pharmaceutical Composition Containing An Anti-Nucleating Agent
|
NA
|
2
| |
|
EP2691112B1 |
23 May, 2018
|
Stable Formulations Of Antibodies To Human Programmed Death Receptor Pd-1 And Related Treatments
|
NA
|
2
| |
|
EP1841493B2 |
29 May, 2024
|
Applicator For Inserting An Implant
|
NA
|
1
| |
|
EP2981821B2 |
03 Nov, 2021
|
Immunohistochemical Assay For Detecting Expression Of Programmed Death Ligand 1 (Pd-L1) In Tumor Tissue
|
NA
|
1
| |
|
EP2931301B2 |
15 Sep, 2021
|
Process For Purifying Insulin And Analogues Thereof
|
NA
|
1
| |
|
EP3283882B1 |
16 Dec, 2020
|
Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists
|
NA
|
1
| |
|
EP3043797B1 |
08 Apr, 2020
|
Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal Function
|
NA
|
1
| |
|
EP3079772B1 |
05 Feb, 2020
|
Immunohistochemical Proximity Assay For Pd-1 Positive Cells And Pd-Ligand Positive Cells In Tumor Tissue
|
NA
|
1
| |
|
EP2475388B1 |
08 Nov, 2017
|
Use Of Il-33 Antagonists To Treat Fibrotic Disease
|
NA
|
1
| |
